MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14796678.2025.2506350

Медицинская библиотека · Future cardiology · 2025

Effect of angiotensin receptor neprilysin inhibitors in patients with STEMI: a systematic review and meta-analysis.

Ahmed Aymen, Sohail Muhammad Umer, Saad Muhammad, Naveed Zara, Arshad Muhammad Sameer, Jawed Areesha, Musheer Adeena, Paracha Anousheh Awais, Siddiqi Ahmed Kamal, Paryani Neha Saleem, Shahid Izza, Memon Muhammad Mustafa

СтатьяМетаанализСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

ST-segment elevation myocardial infarction (STEMI) is responsible for high morbidity and mortality rates globally. Although the use of angiotensin-converting enzyme inhibitors (ACEIs) remains the cornerstone treatment for patients with STEMI, the use of angiotensin-receptor neprilysin inhibitors (ARNIs) may offer better outcomes than ACEIs. This meta-analysis compares the efficacy and safety of ARNIs versus ACEIs in patients with STEMI.

METHODS

Randomized controlled trials (RCTs) were pooled from PubMed and Cochrane databases. A random-effects model calculated risk ratios (RRs) and weighted mean differences (WMDs) with 95% confidence intervals (CIs).

RESULTS

Five trials (n = 4,915) were included. ARNIs significantly reduced major adverse cardiovascular events (MACE) (RR: 0.66, 95% CI [0.50, 0.86]; p = 0.002) and hospitalizations for heart failure (HHF) (RR: 0.67, 95% CI [0.49, 0.92]; p = 0.01). ARNIs also improved left ventricular ejection fraction (LVEF) (WMD: 2.60, 95% CI[1.53, 3.68]; p < 0.00001) and lowered NT-proBNP levels (WMD: -268.89, 95% CI[-422.35, -115.42]; p = 0.0006). No significant differences were observed in recurrent myocardial infarction, cardiovascular death, or safety outcomes - except for hypotension, which was significantly more common with ARNI use.

CONCLUSIONS

ARNI therapy reduces MACE, HHF, and NT-proBNP levels and improves LVEF in patients with STEMI without increasing safety risks, except for hypotension. Further RCTs are needed to confirm these findings.

Для цитирования: Ahmed Aymen, Sohail Muhammad Umer, Saad Muhammad, Naveed Zara, Arshad Muhammad Sameer, Jawed Areesha, Musheer Adeena, Paracha Anousheh Awais, Siddiqi Ahmed Kamal, Paryani Neha Saleem, Shahid Izza, Memon Muhammad Mustafa. Effect of angiotensin receptor neprilysin inhibitors in patients with STEMI: a systematic review and meta-analysis.. Future cardiology. 2025. DOI: 10.1080/14796678.2025.2506350.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.